Richard K. Harrison

Richard K. Harrison has extensive experience in the biotechnology and pharmaceutical industries, holding senior positions in various companies. Richard K. most recently served as the Vice President of Biosciences at Aitia since January 2023. Prior to that, they worked as the Chief Scientist at Causaly from March 2022 to November 2022. From June 2021 to March 2022, they were a Senior Director at Acorn AI. Richard also served as the Head of Research and Development at PERCAYAI from January 2021 to June 2021.

Before these roles, Richard worked at Accenture as a Senior Manager from August 2018 to January 2021, where they were involved in the INTIENT Research platform strategy and collaborated with pharmaceutical and biotech clients. Richard K. also served as the Chief Scientific Officer at Clarivate Analytics from August 2010 to August 2018.

Richard's earlier experience includes senior positions at Wyeth Pharmaceuticals, Vitae Pharmaceuticals, DuPont Pharmaceuticals, and Rhone-Poulenc Rorer. At Wyeth Pharmaceuticals, they were a Senior Director of Biochemical and Cellular Sciences, leading a team of scientists. At DuPont Pharmaceuticals, they served as the Director of High Throughput Screening, managing a group of scientists in lead discovery. Richard was also a Director at Rhone-Poulenc Rorer, where they coordinated the efforts of the Leads Group.

Throughout their career, Richard has demonstrated expertise in research and development, AI-enabled drug discovery, and strategic collaboration with pharmaceutical companies. Richard K. has published and presented research findings in conferences and publications.

Richard K. Harrison earned their Master's degree in Chemistry from Rutgers University, where they studied from 1982 to 1986. Following their Master's degree, they pursued further education at Rutgers University - Newark, from 1990 to 1994, obtaining a Ph.D. in Biochemistry.